GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Net-Net Working Capital

Gerresheimer AG (XTER:GXI) Net-Net Working Capital : €-44.04 (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Gerresheimer AG's Net-Net Working Capital for the quarter that ended in Feb. 2024 was €-44.04.

The industry rank for Gerresheimer AG's Net-Net Working Capital or its related term are showing as below:

XTER:GXI's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 6.5
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Gerresheimer AG Net-Net Working Capital Historical Data

The historical data trend for Gerresheimer AG's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Net-Net Working Capital Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.19 -43.86 -47.02 -51.97 -42.74

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -46.30 -38.79 -40.64 -42.74 -44.04

Competitive Comparison of Gerresheimer AG's Net-Net Working Capital

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's Price-to-Net-Net-Working-Capital Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's Price-to-Net-Net-Working-Capital falls into.



Gerresheimer AG Net-Net Working Capital Calculation

Gerresheimer AG's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Nov. 2023 is calculated as

Net-Net Working Capital(A: Nov. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(136.751+0.75 * 278.383+0.5 * 323.343-1956.772
-0-26.707)/34.54
=-42.74

Gerresheimer AG's Net-Net Working Capital (NNWC) per share for the quarter that ended in Feb. 2024 is calculated as

Net-Net Working Capital(Q: Feb. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(123.17+0.75 * 282.516+0.5 * 350.999-2007.035
-0-24.578)/34.54
=-44.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Gerresheimer AG  (XTER:GXI) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Gerresheimer AG Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines